UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors

Cancer, 2023-05, Vol.129 (10), p.1537-1546

2023

Volltextzugriff (PDF)

A phase 2a safety run-in and preliminary efficacy study of liposomal gemcitabine (FF-10832) in combination with pembrolizumab in patients with advanced solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.2615-2615

2024

Volltextzugriff (PDF)

Preliminary efficacy from an ongoing phase 1 dose escalation study of seclidemstat (SP-2577) in patients (pts) with advanced solid tumors (AST)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3073-3073

2021

Volltextzugriff (PDF)

A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3101-3101

2022

Volltextzugriff (PDF)

Phase 1 expansion trial of the LSD1 inhibitor seclidemstat (SP-2577) with and without topotecan and cyclophosphamide (TC) in patients (pts) with relapsed or refractory Ewing sarcoma (ES) and select sarcomas

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS11577-TPS11577

2021

Volltextzugriff (PDF)

Phase 1 trial of seclidemstat (SP-2577) in patients with relapsed/refractory Ewing sarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11514-11514

2021

Volltextzugriff (PDF)

Phase I expansion study of P-cadherin-targeted 90Y-FF-21101 antibody in advanced chemorefractory colorectal and pancreatic-biliary cancers

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.78-78

2021

Volltextzugriff (PDF)

A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3097-3097

2022

Volltextzugriff (PDF)

A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS11567-TPS11567

2020

Volltextzugriff (PDF)

Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3008-3008

2019

Volltextzugriff (PDF)

Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma

American journal of hematology, 1998-08, Vol.58 (4), p.285-292

1998

Volltextzugriff (PDF)

Case in Point

Hospital Practice, 1997-06, Vol.32 (6), p.19-19

1997

Volltextzugriff (PDF)

Incidence, risk factors and management of venous thromboembolisms in patients with primary CNS lymphoma (2092)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Expected Gamma-Ray Burst Detection Rates and Redshift Distributions for the BlackCAT CubeSat Mission

The Astrophysical journal, 2024-07, Vol.969 (2), p.138

2024

Volltextzugriff (PDF)

Comparison of strategies for assessment of rate of torque development in older and younger adults

European journal of applied physiology, 2024-02, Vol.124 (2), p.551-560

2024

Volltextzugriff (PDF)

SRC-mediated EGF receptor activation regulates ozone-induced interleukin 8 expression in human bronchial epithelial cells

Environmental health perspectives, 2015-03, Vol.123 (3), p.231-231

2015

Volltextzugriff (PDF)

Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma

Journal of neuro-oncology, 2021-08, Vol.154 (1), p.41-47

2021

Volltextzugriff (PDF)

Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology

JNCI : Journal of the National Cancer Institute, 2019-02, Vol.111 (2), p.118-128

2019

Volltextzugriff (PDF)

Reduced Neural Excitability and Activation Contribute to Clinically Meaningful Weakness in Older Adults

The journals of gerontology. Series A, Biological sciences and medical sciences, 2021-04, Vol.76 (4), p.692-702

2021

Volltextzugriff (PDF)

Anti-obesity therapies

Nature reviews. Drug discovery, 2006-05, Vol.5 (5), p.369-370

2006

Volltextzugriff (PDF)

Relative contribution of muscle strength, lean mass, and lower extremity motor function in explaining between-person variance in mobility in older adults

BMC geriatrics, 2020-07, Vol.20 (1), p.255-255, Article 255

2020

Volltextzugriff (PDF)

Reductions in Motor Unit Firing are Associated with Clinically Meaningful Leg Extensor Weakness in Older Adults

Calcified tissue international, 2024-01, Vol.114 (1), p.9-23

2024

Volltextzugriff (PDF)

Change in parathyroid hormone levels from baseline predicts hypocalcemia following total or completion thyroidectomy

Head & neck, 2022-07, Vol.44 (7), p.1588-1595

2022

Volltextzugriff (PDF)

Correction to: Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma

Journal of neuro-oncology, 2021-08, Vol.154 (1), p.49-49

2021

Volltextzugriff (PDF)

MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma

Frontiers in oncology, 2021-01, Vol.10, p.585551-585551

2021

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(73)
Dissertationen
(2)

Sprache

Englisch
(75)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(33)
Humans
(25)
Aged
(13)
Male
(12)
Female
(11)
Oncology
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Middle Aged
(8)
Adult
(7)
Hematology
(7)
Medicine
(7)
Medicine & Public Health
(7)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(6)
Physical Sciences
(6)
Sarcopenia
(6)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(6)
Tumors
(6)
Engineering
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors

A phase 2a safety run-in and preliminary efficacy study of liposomal gemcitabine (FF-10832) in combination with pembrolizumab in patients with advanced solid tumors

Preliminary efficacy from an ongoing phase 1 dose escalation study of seclidemstat (SP-2577) in patients (pts) with advanced solid tumors (AST)

A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors

Phase 1 expansion trial of the LSD1 inhibitor seclidemstat (SP-2577) with and without topotecan and cyclophosphamide (TC) in patients (pts) with relapsed or refractory Ewing sarcoma (ES) and select sarcomas

Phase 1 trial of seclidemstat (SP-2577) in patients with relapsed/refractory Ewing sarcoma

Phase I expansion study of P-cadherin-targeted 90Y-FF-21101 antibody in advanced chemorefractory colorectal and pancreatic-biliary cancers

A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors

A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma

Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors

Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma

Case in Point

Incidence, risk factors and management of venous thromboembolisms in patients with primary CNS lymphoma (2092)

Expected Gamma-Ray Burst Detection Rates and Redshift Distributions for the BlackCAT CubeSat Mission

Comparison of strategies for assessment of rate of torque development in older and younger adults

SRC-mediated EGF receptor activation regulates ozone-induced interleukin 8 expression in human bronchial epithelial cells

Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma

Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology

Reduced Neural Excitability and Activation Contribute to Clinically Meaningful Weakness in Older Adults

Anti-obesity therapies

Relative contribution of muscle strength, lean mass, and lower extremity motor function in explaining between-person variance in mobility in older adults

Reductions in Motor Unit Firing are Associated with Clinically Meaningful Leg Extensor Weakness in Older Adults

Change in parathyroid hormone levels from baseline predicts hypocalcemia following total or completion thyroidectomy

Correction to: Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma

MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma

Suchergebnisse filtern